ZINC OXIDE 20%

ZINC OXIDE 20% was reported 1980 times

ZINC OXIDE 20% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 148 0.4884
1 AMYLOID ARTHROPATHY 29 0.4143
2 TRANSFERRIN SATURATION ABNORMAL 5 0.2941
3 FEMALE GENITAL TRACT FISTULA 159 0.0930
4 TOTAL LUNG CAPACITY INCREASED 23 0.0846
5 CARBUNCLE 23 0.0813
6 PRODUCT ADMINISTRATION ISSUE 14 0.0670
7 RADICULOPATHY 154 0.0584
8 ANAL INFLAMMATION 37 0.0579
9 CHRONIC SINUSITIS 198 0.0527
10 PROCTITIS 147 0.0524
11 SARS-COV-2 TEST NEGATIVE 33 0.0489
12 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 23 0.0440
13 MACULAR DEGENERATION 460 0.0385
14 ASYMPTOMATIC BACTERIURIA 5 0.0368
15 MONOCLONAL IMMUNOGLOBULIN PRESENT 22 0.0289
16 ANAL EROSION 3 0.0273
17 WRIST DEFORMITY 15 0.0244
18 DERMATOPHYTOSIS 5 0.0176
19 SERUM FERRITIN ABNORMAL 5 0.0156
20 GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0154
21 HYPOTHALAMO-PITUITARY DISORDER 22 0.0151
22 NASAL FLARING 2 0.0148
23 VAGINAL DISCHARGE 148 0.0146
24 PARAESTHESIA ORAL 198 0.0137
25 MUCOSAL HYPERTROPHY 2 0.0135
26 MIGRAINE WITHOUT AURA 4 0.0133
27 NEUROBLASTOMA 5 0.0131
28 NUCLEAR MAGNETIC RESONANCE IMAGING 2 0.0120
29 ORAL CANDIDIASIS 149 0.0113
30 CREATININE RENAL CLEARANCE ABNORMAL 5 0.0108
31 PULMONARY PAIN 30 0.0103
32 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
33 NODULAR RASH 2 0.0090
34 EPILEPTIC ENCEPHALOPATHY 2 0.0090
35 MENINGOENCEPHALITIS HERPETIC 4 0.0089
36 FEEDING INTOLERANCE 4 0.0089
37 PROCTALGIA 56 0.0087
38 DERMATITIS DIAPER 6 0.0085
39 NEUROGENIC BOWEL 2 0.0084
40 GINGIVAL ERYTHEMA 7 0.0081
41 FIBROSIS 22 0.0071
42 ALVEOLAR OSTEITIS 3 0.0071
43 JARISCH-HERXHEIMER REACTION 5 0.0070
44 BURSA DISORDER 2 0.0069
45 PROCEDURAL PAIN 190 0.0068
46 JAUNDICE CHOLESTATIC 23 0.0065
47 HYPOMANIA 23 0.0062
48 PENILE ULCERATION 2 0.0061
49 SKIN CANDIDA 3 0.0057
50 CHRONIC RESPIRATORY DISEASE 2 0.0057
51 FREQUENT BOWEL MOVEMENTS 153 0.0057
52 XEROSIS 7 0.0057
53 FAT EMBOLISM 2 0.0056
54 RHINITIS ALLERGIC 25 0.0056
55 PNEUMONIA STREPTOCOCCAL 6 0.0055
56 TINEA INFECTION 6 0.0054
57 INJECTION SITE ULCER 5 0.0053
58 LIFE EXPECTANCY SHORTENED 3 0.0053
59 NASAL POLYPS 26 0.0053
60 AORTIC CALCIFICATION 3 0.0052
61 SARCOIDOSIS 23 0.0048
62 ENTEROCOCCUS TEST POSITIVE 3 0.0046
63 HAEMANGIOMA OF SKIN 2 0.0046
64 FINGER DEFORMITY 22 0.0045
65 DYSLIPIDAEMIA 23 0.0045
66 LICHEN SCLEROSUS 3 0.0044
67 ECZEMA HERPETICUM 2 0.0043
68 DISSEMINATED ASPERGILLOSIS 2 0.0042
69 LANGUAGE DISORDER 9 0.0042
70 OVERWEIGHT 22 0.0041
71 LENTIGO 2 0.0040
72 COLITIS 151 0.0040
73 METASTATIC SQUAMOUS CELL CARCINOMA 2 0.0039
74 BRONCHIECTASIS 26 0.0039
75 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 3 0.0038
76 MUSCLE DISCOMFORT 3 0.0038
77 RECTAL HAEMORRHAGE 163 0.0038
78 BRONCHOPULMONARY DYSPLASIA 3 0.0037
79 GRANULOMA SKIN 3 0.0037
80 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 3 0.0036
81 MILK ALLERGY 2 0.0036
82 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
83 ENTEROVIRUS INFECTION 3 0.0035
84 COLITIS ULCERATIVE 152 0.0034
85 CANDIDA SEPSIS 3 0.0033
86 GRUNTING 2 0.0033
87 CEREBRAL ASPERGILLOSIS 2 0.0033
88 INFUSION RELATED REACTION 201 0.0030
89 RENAL CYST 24 0.0030
90 ACCIDENT 36 0.0030
91 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 214 0.0030
92 CARDIAC MURMUR 26 0.0030
93 KERATOACANTHOMA 2 0.0029
94 ANGULAR CHEILITIS 2 0.0029
95 KIDNEY FIBROSIS 5 0.0029
96 HAEMATOCHEZIA 159 0.0029
97 LEIOMYOMA 2 0.0029
98 PUNCTURE SITE HAEMORRHAGE 2 0.0028
99 ANTIBODY TEST ABNORMAL 2 0.0028
100 APLASTIC ANAEMIA 14 0.0027
101 DYSAESTHESIA 8 0.0026
102 DEBRIDEMENT 2 0.0026
103 PURPURA 23 0.0026
104 NEPHROPATHY 24 0.0026
105 METAPNEUMOVIRUS INFECTION 2 0.0026
106 BICYTOPENIA 5 0.0025
107 CHRONIC RESPIRATORY FAILURE 3 0.0025
108 GUTTATE PSORIASIS 2 0.0024
109 BOTULISM 2 0.0024
110 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
111 LUNG NEOPLASM 10 0.0023
112 MEAN CELL VOLUME INCREASED 6 0.0023
113 RHINOVIRUS INFECTION 9 0.0023
114 BODY HEIGHT DECREASED 24 0.0022
115 DECUBITUS ULCER 18 0.0022
116 PNEUMONIA VIRAL 7 0.0022
117 CERUMEN IMPACTION 2 0.0022
118 RHONCHI 3 0.0022
119 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
120 BIOPSY 2 0.0022
121 HAEMORRHOIDS 42 0.0022
122 FACIAL ASYMMETRY 2 0.0021
123 ANIMAL SCRATCH 2 0.0021
124 COLON ADENOMA 2 0.0020
125 IMPETIGO 3 0.0020
126 DYSPEPSIA 197 0.0020
127 DEVICE RELATED SEPSIS 4 0.0020
128 VASCULAR DEVICE INFECTION 9 0.0020
129 SCHIZOPHRENIA 24 0.0020
130 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
131 IMPLANT SITE SWELLING 2 0.0020
132 BODY TEMPERATURE INCREASED 39 0.0019
133 HYPOPERFUSION 2 0.0019
134 NEUROMYOPATHY 2 0.0019
135 OBESITY 29 0.0018
136 CLOSTRIDIUM TEST POSITIVE 4 0.0018
137 OPEN WOUND 2 0.0018
138 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
139 BLOOD FIBRINOGEN DECREASED 2 0.0018
140 OPEN REDUCTION OF FRACTURE 2 0.0017
141 PERIPHERAL EMBOLISM 2 0.0017
142 ACUTE PRERENAL FAILURE 2 0.0017
143 JOINT RANGE OF MOTION DECREASED 23 0.0017
144 FANCONI SYNDROME ACQUIRED 3 0.0017
145 ESCHERICHIA BACTERAEMIA 4 0.0017
146 SCIATICA 27 0.0017
147 MONOCYTE COUNT DECREASED 2 0.0016
148 HYPERPARATHYROIDISM SECONDARY 4 0.0016
149 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
150 BRONCHIAL SECRETION RETENTION 2 0.0016
151 CANCER PAIN 4 0.0016
152 CUSHINGOID 5 0.0016
153 CHOLELITHIASIS 49 0.0015
154 SKIN DISCOMFORT 4 0.0015
155 CARBON DIOXIDE INCREASED 2 0.0015
156 APPLICATION SITE INFLAMMATION 2 0.0014
157 GRANULOMA 5 0.0014
158 INCISIONAL HERNIA 2 0.0014
159 NEUROGENIC BLADDER 3 0.0014
160 CATAPLEXY 2 0.0014
161 NEUROENDOCRINE TUMOUR 2 0.0014
162 GENITAL RASH 2 0.0014
163 HEPATIC STEATOSIS 26 0.0014
164 ACUTE ABDOMEN 2 0.0014
165 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
166 FOOT DEFORMITY 15 0.0014
167 HEPATOTOXICITY 30 0.0013
168 PITUITARY TUMOUR 2 0.0013
169 METABOLIC ENCEPHALOPATHY 4 0.0013
170 SYNOVITIS 24 0.0013
171 PEMPHIGOID 10 0.0013
172 REBOUND ACID HYPERSECRETION 4 0.0013
173 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
174 MEAN CELL VOLUME DECREASED 2 0.0013
175 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
176 OSTEOSCLEROSIS 2 0.0013
177 RALES 7 0.0012
178 KNEE ARTHROPLASTY 25 0.0012
179 EXPOSURE TO SARS-COV-2 2 0.0012
180 PAPILLARY THYROID CANCER 2 0.0011
181 BRONCHIOLITIS 4 0.0011
182 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
183 BREAST SWELLING 3 0.0011
184 EAR CONGESTION 3 0.0011
185 MONOPARESIS 2 0.0011
186 ESSENTIAL HYPERTENSION 2 0.0011
187 FEBRILE NEUTROPENIA 72 0.0011
188 NEPHROGENIC ANAEMIA 5 0.0011
189 BLOOD BILIRUBIN INCREASED 29 0.0011
190 LUNG CONSOLIDATION 3 0.0011
191 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
192 MECHANICAL VENTILATION 2 0.0011
193 PNEUMATOSIS INTESTINALIS 3 0.0011
194 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
195 LIMB INJURY 28 0.0010
196 HYPOALBUMINAEMIA 8 0.0010
197 OCCULT BLOOD POSITIVE 2 0.0010
198 BACTERAEMIA 12 0.0010
199 HYPERNATRAEMIA 5 0.0010
200 MUCOSAL DRYNESS 2 0.0010
201 JOINT STIFFNESS 26 0.0010
202 ANAEMIA 189 0.0010
203 FUNGAL SKIN INFECTION 4 0.0010
204 ARTHROPATHY 55 0.0010
205 RECTAL CANCER 3 0.0010
206 PERIPHERAL VASCULAR DISORDER 5 0.0010
207 HYPERPARATHYROIDISM 2 0.0010
208 FAILURE TO THRIVE 5 0.0010
209 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
210 MICROCYTIC ANAEMIA 2 0.0010
211 PNEUMONIA ASPIRATION 24 0.0010
212 LIVEDO RETICULARIS 2 0.0010
213 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
214 SKIN EROSION 3 0.0009
215 HYPERPHOSPHATAEMIA 2 0.0009
216 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
217 DYSSTASIA 27 0.0009
218 PERIODONTITIS 2 0.0009
219 ONYCHOMYCOSIS 4 0.0009
220 HAEMORRHAGIC ANAEMIA 4 0.0009
221 MIDDLE EAR EFFUSION 2 0.0009
222 CONGENITAL ANOMALY 7 0.0009
223 FAECES PALE 2 0.0009
224 CONSTIPATION 196 0.0009
225 NEPHRITIS 3 0.0009
226 PYREXIA 308 0.0009
227 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
228 BLOOD LOSS ANAEMIA 2 0.0009
229 METASTASES TO MENINGES 2 0.0009
230 PUSTULAR PSORIASIS 3 0.0009
231 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
232 WEIGHT DECREASED 240 0.0009
233 ARTERIOSCLEROSIS 8 0.0008
234 ERYTHEMA 171 0.0008
235 LYMPHADENITIS 2 0.0008
236 FOETAL GROWTH RESTRICTION 5 0.0008
237 HEPATIC ENZYME INCREASED 56 0.0008
238 PSEUDOMONAS INFECTION 7 0.0008
239 ABDOMINAL PAIN 189 0.0008
240 MOVEMENT DISORDER 26 0.0008
241 HYPERVOLAEMIA 4 0.0008
242 DEVICE INFUSION ISSUE 2 0.0008
243 PARANASAL SINUS DISCOMFORT 3 0.0008
244 INCREASED BRONCHIAL SECRETION 2 0.0008
245 PSYCHOTIC DISORDER 23 0.0008
246 CACHEXIA 4 0.0008
247 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
248 WOUND SECRETION 3 0.0008
249 LUNG OPACITY 2 0.0008
250 CEREBRAL ATROPHY 3 0.0008
251 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
252 PROTEIN TOTAL INCREASED 2 0.0008
253 AZOTAEMIA 3 0.0008
254 BLOOD SODIUM INCREASED 2 0.0007
255 ABDOMINAL RIGIDITY 2 0.0007
256 BONE DENSITY DECREASED 23 0.0007
257 CLONUS 2 0.0007
258 DRUG SCREEN FALSE POSITIVE 2 0.0007
259 MACULE 2 0.0007
260 SKIN DISORDER 24 0.0007
261 MALNUTRITION 8 0.0007
262 ANAL HAEMORRHAGE 2 0.0007
263 OSTEOPOROSIS 29 0.0007
264 OXYGEN SATURATION ABNORMAL 2 0.0007
265 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
266 DUODENAL ULCER HAEMORRHAGE 2 0.0007
267 LIP PAIN 2 0.0007
268 SKIN ATROPHY 4 0.0007
269 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
270 PSORIATIC ARTHROPATHY 28 0.0007
271 ADENOVIRUS INFECTION 2 0.0007
272 HAEMOTHORAX 2 0.0007
273 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
274 OSTEOARTHRITIS 29 0.0007
275 HYPOVOLAEMIA 4 0.0007
276 PARONYCHIA 3 0.0007
277 GINGIVAL SWELLING 3 0.0007
278 LYMPHOCYTE COUNT DECREASED 12 0.0007
279 ABDOMINAL ABSCESS 3 0.0007
280 DECREASED INTEREST 4 0.0007
281 DRUG ERUPTION 12 0.0007
282 MYELOFIBROSIS 2 0.0007
283 EMBOLISM VENOUS 2 0.0007
284 CHEST X-RAY ABNORMAL 2 0.0007
285 EYE OPERATION 3 0.0007
286 BLOOD BLISTER 2 0.0006
287 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
288 BLOOD CREATININE DECREASED 2 0.0006
289 ABDOMINAL ADHESIONS 2 0.0006
290 BLADDER PAIN 2 0.0006
291 POLYMYALGIA RHEUMATICA 2 0.0006
292 HYPOXIA 22 0.0006
293 HUMERUS FRACTURE 3 0.0006
294 RASH VESICULAR 3 0.0006
295 DERMATITIS 13 0.0006
296 BACTERIAL SEPSIS 2 0.0006
297 HYPOVENTILATION 2 0.0006
298 HEPATIC NEOPLASM 2 0.0006
299 OEDEMA MOUTH 2 0.0006
300 OTITIS MEDIA 2 0.0006
301 HAEMATOCRIT DECREASED 12 0.0006
302 CORONAVIRUS INFECTION 4 0.0006
303 END STAGE RENAL DISEASE 11 0.0006
304 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
305 EOSINOPHIL COUNT INCREASED 5 0.0006
306 PROSTATE CANCER METASTATIC 2 0.0006
307 CYTOKINE RELEASE SYNDROME 12 0.0006
308 CEREBRAL HAEMATOMA 2 0.0006
309 METASTASES TO SPINE 2 0.0006
310 MALAISE 261 0.0006
311 HEPATIC CYST 2 0.0006
312 LUNG NEOPLASM MALIGNANT 24 0.0006
313 LEFT VENTRICULAR FAILURE 2 0.0006
314 RESPIRATORY DISTRESS 16 0.0006
315 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30 0.0006
316 AORTIC STENOSIS 2 0.0006
317 PAPULE 4 0.0006
318 INCONTINENCE 6 0.0006
319 FACIAL PARESIS 2 0.0006
320 ANORECTAL DISCOMFORT 3 0.0006
321 LIVER DISORDER 25 0.0006
322 FIBRIN D DIMER INCREASED 2 0.0006
323 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
324 ANAL FISSURE 3 0.0006
325 ANAL ABSCESS 3 0.0006
326 HYDROCEPHALUS 3 0.0006
327 FAECALOMA 3 0.0005
328 HYPOPHOSPHATAEMIA 4 0.0005
329 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
330 ARTHROPOD BITE 4 0.0005
331 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
332 STREPTOCOCCAL INFECTION 3 0.0005
333 ORAL PAIN 12 0.0005
334 MUSCULOSKELETAL PAIN 28 0.0005
335 HYDRONEPHROSIS 4 0.0005
336 CANDIDA INFECTION 9 0.0005
337 CATHETER SITE INFECTION 2 0.0005
338 GASTRIC INFECTION 2 0.0005
339 BOWEL MOVEMENT IRREGULARITY 4 0.0005
340 HERPES VIRUS INFECTION 3 0.0005
341 RENAL FAILURE CHRONIC 4 0.0005
342 DEVICE RELATED INFECTION 8 0.0005
343 HYPERCHOLESTEROLAEMIA 5 0.0005
344 ATELECTASIS 5 0.0005
345 FAECES HARD 2 0.0005
346 THERAPY PARTIAL RESPONDER 8 0.0005
347 PULMONARY HAEMORRHAGE 4 0.0005
348 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
349 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
350 WHEEZING 30 0.0005
351 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
352 MYASTHENIA GRAVIS 4 0.0005
353 INGUINAL HERNIA 3 0.0005
354 DERMATITIS ACNEIFORM 3 0.0005
355 PERIPHERAL VENOUS DISEASE 2 0.0005
356 HYPERURICAEMIA 2 0.0005
357 SPINAL COMPRESSION FRACTURE 4 0.0005
358 TRANSFUSION 5 0.0005
359 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
360 FEBRILE BONE MARROW APLASIA 2 0.0005
361 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
362 METASTATIC NEOPLASM 2 0.0005
363 NEUTROPENIA 63 0.0005
364 HYSTERECTOMY 4 0.0005
365 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
366 CHAPPED LIPS 2 0.0005
367 PAIN 282 0.0005
368 MUCOSAL INFLAMMATION 12 0.0005
369 BEDRIDDEN 6 0.0005
370 DYSPHEMIA 2 0.0005
371 PULMONARY CONGESTION 6 0.0005
372 GASTROINTESTINAL PAIN 5 0.0005
373 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
374 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
375 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
376 DIABETES MELLITUS 34 0.0004
377 SKIN INFECTION 5 0.0004
378 METASTASES TO LYMPH NODES 3 0.0004
379 MITRAL VALVE INCOMPETENCE 5 0.0004
380 TACHYPNOEA 6 0.0004
381 SEPSIS 49 0.0004
382 DERMATITIS CONTACT 5 0.0004
383 SCAB 5 0.0004
384 DROOLING 3 0.0004
385 INTENTIONAL PRODUCT MISUSE 38 0.0004
386 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
387 MENTAL STATUS CHANGES 12 0.0004
388 CONJUNCTIVITIS 8 0.0004
389 ARTHRITIS INFECTIVE 2 0.0004
390 HYPOPHAGIA 11 0.0004
391 ERYTHEMA MULTIFORME 4 0.0004
392 DEFORMITY 4 0.0004
393 METASTASES TO BONE 7 0.0004
394 STAPHYLOCOCCAL INFECTION 14 0.0004
395 PULMONARY TOXICITY 3 0.0004
396 COVID-19 PNEUMONIA 5 0.0004
397 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
398 DIVERTICULUM 3 0.0004
399 BLOOD URINE PRESENT 8 0.0004
400 PROTEINURIA 8 0.0004
401 SUBDURAL HAEMATOMA 6 0.0004
402 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
403 HYPERLIPIDAEMIA 5 0.0004
404 CELLULITIS 21 0.0004
405 GASTROINTESTINAL TOXICITY 2 0.0004
406 DERMATITIS BULLOUS 3 0.0004
407 SEPTIC SHOCK 18 0.0004
408 FAECES SOFT 3 0.0004
409 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
410 CARDIOMYOPATHY 6 0.0004
411 OEDEMA 22 0.0004
412 MUCOUS STOOLS 2 0.0004
413 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
414 DELIRIUM 14 0.0004
415 TOOTH EXTRACTION 5 0.0004
416 HYPERAMMONAEMIA 2 0.0004
417 ERYSIPELAS 2 0.0004
418 DRUG INEFFECTIVE 523 0.0004
419 PRODUCT ADMINISTRATION ERROR 8 0.0004
420 HYPOTHERMIA 4 0.0004
421 CHILLS 46 0.0004
422 SLUGGISHNESS 4 0.0004
423 CEREBRAL ISCHAEMIA 2 0.0004
424 OFF LABEL USE 339 0.0004
425 SKIN ULCER 10 0.0004
426 LEUKOCYTOSIS 7 0.0004
427 POOR VENOUS ACCESS 4 0.0004
428 HIATUS HERNIA 5 0.0004
429 HAEMORRHAGIC STROKE 3 0.0004
430 RESPIRATORY FAILURE 28 0.0004
431 HERPES ZOSTER 22 0.0004
432 AFFECTIVE DISORDER 3 0.0004
433 ARTHRITIS 30 0.0004
434 FURUNCLE 3 0.0004
435 BLOOD ALBUMIN DECREASED 3 0.0004
436 RENAL PAIN 4 0.0004
437 GINGIVAL PAIN 3 0.0004
438 ANAL FISTULA 2 0.0004
439 TRANSPLANT REJECTION 3 0.0004
440 BACK PAIN 87 0.0004
441 NAUSEA 296 0.0004
442 URINARY INCONTINENCE 11 0.0004
443 GINGIVITIS 2 0.0004
444 MUSCLE DISORDER 3 0.0004
445 FIBROMYALGIA 9 0.0004
446 BLOOD POTASSIUM INCREASED 6 0.0004
447 HYPOKALAEMIA 17 0.0004
448 NORMAL NEWBORN 2 0.0004
449 SKIN LACERATION 4 0.0004
450 INTESTINAL ISCHAEMIA 2 0.0004
451 HYPERKERATOSIS 2 0.0004
452 CYSTIC FIBROSIS 2 0.0004
453 OEDEMA PERIPHERAL 44 0.0004
454 DRUG ABUSE 30 0.0004
455 BLOOD UREA INCREASED 6 0.0004
456 SKIN FISSURES 7 0.0004
457 BLOOD TEST ABNORMAL 5 0.0004
458 MUSCULOSKELETAL STIFFNESS 31 0.0004
459 BLOOD CREATININE INCREASED 23 0.0004
460 INTERNAL HAEMORRHAGE 4 0.0003
461 HYPERTONIA 2 0.0003
462 LETHARGY 20 0.0003
463 BLOOD URIC ACID INCREASED 2 0.0003
464 PYELONEPHRITIS 3 0.0003
465 TASTE DISORDER 7 0.0003
466 CHRONIC KIDNEY DISEASE 26 0.0003
467 BLOOD IRON DECREASED 4 0.0003
468 CATARACT OPERATION 2 0.0003
469 ANAL INCONTINENCE 3 0.0003
470 OSTEOMYELITIS 6 0.0003
471 PNEUMONITIS 9 0.0003
472 HEADACHE 206 0.0003
473 CEREBRAL INFARCTION 8 0.0003
474 MUSCLE SPASTICITY 4 0.0003
475 IRON DEFICIENCY ANAEMIA 3 0.0003
476 HYPERCALCAEMIA 4 0.0003
477 PHARYNGITIS 4 0.0003
478 OLIGURIA 2 0.0003
479 DEMENTIA 9 0.0003
480 INFUSION SITE SWELLING 2 0.0003
481 BLEPHAROSPASM 2 0.0003
482 SPINAL DISORDER 3 0.0003
483 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
484 ABSCESS 5 0.0003
485 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
486 PULMONARY OEDEMA 14 0.0003
487 PLEURAL EFFUSION 19 0.0003
488 ACUTE RESPIRATORY FAILURE 6 0.0003
489 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
490 SINUS BRADYCARDIA 3 0.0003
491 ANAPHYLACTIC SHOCK 8 0.0003
492 DIZZINESS POSTURAL 3 0.0003
493 RENAL FAILURE 41 0.0003
494 THROMBOTIC MICROANGIOPATHY 3 0.0003
495 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
496 DEAFNESS 8 0.0003
497 RENAL TUBULAR NECROSIS 3 0.0003
498 PNEUMONIA 99 0.0003
499 ECZEMA 16 0.0003
500 IMPAIRED HEALING 10 0.0003
501 HOSPICE CARE 3 0.0003
502 LIGAMENT SPRAIN 3 0.0003
503 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
504 HYPONATRAEMIA 17 0.0003
505 URINARY RETENTION 10 0.0003
506 DYSURIA 11 0.0003
507 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
508 TOXIC SKIN ERUPTION 3 0.0003
509 PAIN OF SKIN 8 0.0003
510 BONE MARROW FAILURE 6 0.0003
511 HEPATIC FUNCTION ABNORMAL 11 0.0003
512 RASH ERYTHEMATOUS 14 0.0003
513 BLOOD TESTOSTERONE DECREASED 2 0.0003
514 INFARCTION 2 0.0003
515 EYE MOVEMENT DISORDER 2 0.0003
516 HAEMATURIA 10 0.0003
517 LYMPHOEDEMA 2 0.0003
518 EYE DISCHARGE 3 0.0003
519 HYPOMAGNESAEMIA 4 0.0003
520 ORTHOSTATIC HYPOTENSION 5 0.0003
521 HAEMOPTYSIS 8 0.0003
522 MASS 4 0.0003
523 HYPERKALAEMIA 10 0.0003
524 ENCEPHALOPATHY 7 0.0003
525 OXYGEN SATURATION DECREASED 16 0.0003
526 FULL BLOOD COUNT ABNORMAL 3 0.0003
527 LYMPHADENOPATHY 10 0.0003
528 HEAD DISCOMFORT 5 0.0003
529 GAIT DISTURBANCE 54 0.0003
530 EATING DISORDER 6 0.0003
531 SINUS TACHYCARDIA 4 0.0003
532 RETCHING 6 0.0003
533 JOINT INJURY 6 0.0003
534 IMPAIRED QUALITY OF LIFE 4 0.0003
535 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
536 GASTROENTERITIS 4 0.0003
537 ASPIRATION 3 0.0003
538 DENTAL CARIES 3 0.0003
539 VIRAL INFECTION 9 0.0003
540 VENTRICULAR FIBRILLATION 3 0.0003
541 FUNGAL INFECTION 9 0.0003
542 BACTERIAL INFECTION 5 0.0003
543 VOMITING 125 0.0003
544 STATUS EPILEPTICUS 3 0.0003
545 BREAST TENDERNESS 2 0.0003
546 FLATULENCE 15 0.0003
547 HYPERTENSION 56 0.0003
548 HYPOCALCAEMIA 5 0.0003
549 URINARY TRACT INFECTION 45 0.0003
550 MYOCARDIAL ISCHAEMIA 3 0.0003
551 OSTEOPENIA 4 0.0003
552 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
553 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
554 SLEEP APNOEA SYNDROME 5 0.0003
555 ACUTE KIDNEY INJURY 40 0.0003
556 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
557 SEROTONIN SYNDROME 5 0.0003
558 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
559 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
560 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
561 ELECTROLYTE IMBALANCE 3 0.0003
562 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
563 APHTHOUS ULCER 2 0.0003
564 EAR PAIN 5 0.0003
565 DIARRHOEA 166 0.0003
566 ABDOMINAL DISCOMFORT 43 0.0003
567 SPINAL PAIN 3 0.0003
568 PRODUCT USE COMPLAINT 4 0.0003
569 PSORIASIS 33 0.0003
570 PNEUMOTHORAX 4 0.0003
571 SEIZURE 29 0.0003
572 MUSCLE RIGIDITY 3 0.0003
573 PRESCRIBED UNDERDOSE 5 0.0003
574 PANCYTOPENIA 14 0.0003
575 BLOOD DISORDER 2 0.0002
576 RHINORRHOEA 16 0.0002
577 ADRENAL INSUFFICIENCY 3 0.0002
578 NEUTROPHIL COUNT DECREASED 10 0.0002
579 HYPERSOMNIA 7 0.0002
580 ABNORMAL FAECES 2 0.0002
581 CARDIOMEGALY 3 0.0002
582 OSTEONECROSIS OF JAW 6 0.0002
583 EYE SWELLING 9 0.0002
584 PERITONITIS 5 0.0002
585 ILEUS 3 0.0002
586 HEMIPLEGIA 2 0.0002
587 COAGULOPATHY 4 0.0002
588 OROPHARYNGEAL PAIN 22 0.0002
589 BRAIN OEDEMA 3 0.0002
590 MUSCLE ATROPHY 3 0.0002
591 RESPIRATORY DISORDER 7 0.0002
592 HAEMOGLOBIN DECREASED 24 0.0002
593 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
594 ANURIA 2 0.0002
595 HAEMATOMA 6 0.0002
596 MYOPATHY 2 0.0002
597 PRURITUS GENERALISED 5 0.0002
598 MUSCLE STRAIN 2 0.0002
599 STOMATITIS 14 0.0002
600 DEEP VEIN THROMBOSIS 15 0.0002
601 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
602 FAECES DISCOLOURED 5 0.0002
603 AMENORRHOEA 4 0.0002
604 BLOOD CALCIUM INCREASED 2 0.0002
605 IMMUNE SYSTEM DISORDER 3 0.0002
606 TOOTH INFECTION 3 0.0002
607 PRODUCT COMMUNICATION ISSUE 2 0.0002
608 LUNG INFILTRATION 2 0.0002
609 CONDITION AGGRAVATED 68 0.0002
610 THROMBOCYTOPENIA 25 0.0002
611 HAEMOLYTIC ANAEMIA 2 0.0002
612 GASTROINTESTINAL INFECTION 2 0.0002
613 C-REACTIVE PROTEIN INCREASED 8 0.0002
614 CYSTITIS 7 0.0002
615 BONE DISORDER 4 0.0002
616 EXOSTOSIS 2 0.0002
617 SKIN LESION 6 0.0002
618 ASTHENIA 82 0.0002
619 PNEUMONIA BACTERIAL 2 0.0002
620 DIVERTICULITIS 6 0.0002
621 BRONCHITIS 16 0.0002
622 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
623 FEELING COLD 6 0.0002
624 INFLUENZA 24 0.0002
625 HEPATIC ENCEPHALOPATHY 2 0.0002
626 APPENDICITIS 2 0.0002
627 BURNING SENSATION 15 0.0002
628 FLANK PAIN 2 0.0002
629 CARDIAC FAILURE CONGESTIVE 17 0.0002
630 DEHYDRATION 28 0.0002
631 CARDIOGENIC SHOCK 3 0.0002
632 HERNIA 4 0.0002
633 HYPOKINESIA 3 0.0002
634 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
635 NEURALGIA 5 0.0002
636 ATRIAL FIBRILLATION 20 0.0002
637 AUTOIMMUNE DISORDER 2 0.0002
638 PARKINSONISM 2 0.0002
639 CHOKING 4 0.0002
640 RASH 89 0.0002
641 LUNG DISORDER 10 0.0002
642 KIDNEY INFECTION 4 0.0002
643 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
644 SKIN HAEMORRHAGE 3 0.0002
645 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
646 RENAL INJURY 6 0.0002
647 SINUS DISORDER 4 0.0002
648 BLADDER DISORDER 2 0.0002
649 PULMONARY MASS 3 0.0002
650 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
651 FALL 67 0.0002
652 BLOOD PRESSURE ABNORMAL 4 0.0002
653 HAEMORRHAGE INTRACRANIAL 3 0.0002
654 HYPOAESTHESIA ORAL 3 0.0002
655 EMPHYSEMA 2 0.0002
656 HAEMATEMESIS 5 0.0002
657 PRODUCT DOSE OMISSION ISSUE 58 0.0002
658 DEVICE FAILURE 3 0.0002
659 EYELID PTOSIS 2 0.0002
660 NEUTROPHIL COUNT INCREASED 2 0.0002
661 ERECTILE DYSFUNCTION 5 0.0002
662 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
663 FEMUR FRACTURE 6 0.0002
664 HYPERBILIRUBINAEMIA 2 0.0002
665 DIPLOPIA 5 0.0002
666 ACUTE MYELOID LEUKAEMIA 3 0.0002
667 PULMONARY HYPERTENSION 4 0.0002
668 RESPIRATORY TRACT INFECTION 5 0.0002
669 SEDATION 5 0.0002
670 MOUTH ULCERATION 4 0.0002
671 HYPOTENSION 38 0.0002
672 ULCER 3 0.0002
673 BONE PAIN 11 0.0002
674 EPISTAXIS 14 0.0002
675 HIP FRACTURE 6 0.0002
676 DYSPNOEA EXERTIONAL 7 0.0002
677 HYPOGLYCAEMIA 9 0.0002
678 PHARYNGITIS STREPTOCOCCAL 2 0.0002
679 PALLOR 5 0.0002
680 CHEST PAIN 34 0.0002
681 OESOPHAGITIS 2 0.0002
682 MELAENA 4 0.0002
683 APPLICATION SITE PAIN 4 0.0002
684 DRUG LEVEL INCREASED 3 0.0002
685 CYTOMEGALOVIRUS INFECTION 3 0.0002
686 STEVENS-JOHNSON SYNDROME 4 0.0002
687 MEDICATION ERROR 10 0.0002
688 WOUND 5 0.0002
689 RENAL IMPAIRMENT 15 0.0002
690 SNEEZING 4 0.0002
691 PLATELET COUNT DECREASED 19 0.0002
692 SKIN EXFOLIATION 15 0.0002
693 DECREASED APPETITE 41 0.0002
694 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
695 NEOPLASM 2 0.0002
696 SHOCK 4 0.0002
697 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
698 MULTI-ORGAN FAILURE 3 0.0002
699 METASTASES TO LUNG 2 0.0002
700 PERICARDIAL EFFUSION 4 0.0002
701 EYELID OEDEMA 2 0.0002
702 BLOOD CHOLESTEROL INCREASED 8 0.0002
703 ASCITES 5 0.0002
704 ACUTE MYOCARDIAL INFARCTION 5 0.0002
705 TACHYCARDIA 15 0.0002
706 DRUG DEPENDENCE 27 0.0002
707 CHOLECYSTITIS 2 0.0002
708 POLLAKIURIA 7 0.0002
709 BLOOD PRESSURE FLUCTUATION 4 0.0002
710 INFECTION 24 0.0002
711 TOOTHACHE 3 0.0002
712 RENAL FAILURE ACUTE 7 0.0002
713 BURSITIS 2 0.0002
714 NEOPLASM MALIGNANT 11 0.0002
715 NOCTURIA 2 0.0002
716 PANIC ATTACK 6 0.0002
717 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
718 DISCOMFORT 10 0.0002
719 EPILEPSY 5 0.0002
720 ARTHRALGIA 68 0.0002
721 CYTOPENIA 2 0.0002
722 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
723 OVERDOSE 35 0.0002
724 CARDIAC FAILURE 13 0.0002
725 GENERALISED OEDEMA 2 0.0002
726 BLISTER 9 0.0002
727 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
728 COVID-19 28 0.0002
729 DYSARTHRIA 6 0.0002
730 PULMONARY EMBOLISM 15 0.0002
731 METABOLIC ACIDOSIS 5 0.0002
732 THERAPY NON-RESPONDER 7 0.0002
733 NIGHT SWEATS 5 0.0002
734 LACTIC ACIDOSIS 5 0.0002
735 ORAL HERPES 3 0.0002
736 ABDOMINAL DISTENSION 16 0.0002
737 SPEECH DISORDER 8 0.0002
738 NEPHROLITHIASIS 7 0.0002
739 SPINAL FRACTURE 3 0.0001
740 HAIR TEXTURE ABNORMAL 2 0.0001
741 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
742 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
743 FLUSHING 15 0.0001
744 DYSPHAGIA 14 0.0001
745 IMPAIRED GASTRIC EMPTYING 2 0.0001
746 SINUSITIS 15 0.0001
747 RIB FRACTURE 3 0.0001
748 PERIPHERAL COLDNESS 2 0.0001
749 INTERSTITIAL LUNG DISEASE 7 0.0001
750 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
751 SOMNOLENCE 29 0.0001
752 ORAL DISCOMFORT 2 0.0001
753 CONFUSIONAL STATE 23 0.0001
754 DEVICE OCCLUSION 2 0.0001
755 HALLUCINATION, VISUAL 3 0.0001
756 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
757 PAIN IN JAW 4 0.0001
758 DIALYSIS 2 0.0001
759 MUSCULAR WEAKNESS 16 0.0001
760 LOSS OF CONSCIOUSNESS 18 0.0001
761 DRY EYE 7 0.0001
762 BRONCHOSPASM 2 0.0001
763 LIVER FUNCTION TEST INCREASED 3 0.0001
764 PARALYSIS 2 0.0001
765 ANGINA PECTORIS 4 0.0001
766 PRODUCT USE ISSUE 26 0.0001
767 PRODUCT PRESCRIBING ISSUE 3 0.0001
768 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
769 HYPERGLYCAEMIA 5 0.0001
770 ACCIDENTAL OVERDOSE 5 0.0001
771 INFLAMMATION 7 0.0001
772 ANGIOEDEMA 6 0.0001
773 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
774 INJECTION SITE MASS 5 0.0001
775 IMMUNODEFICIENCY 2 0.0001
776 BLOOD POTASSIUM DECREASED 4 0.0001
777 HEART RATE IRREGULAR 3 0.0001
778 HEPATIC FAILURE 4 0.0001
779 INTESTINAL OBSTRUCTION 5 0.0001
780 APHASIA 4 0.0001
781 ILL-DEFINED DISORDER 8 0.0001
782 SKIN IRRITATION 6 0.0001
783 HIP ARTHROPLASTY 2 0.0001
784 FEELING HOT 8 0.0001
785 PHARYNGEAL OEDEMA 2 0.0001
786 MUSCULOSKELETAL CHEST PAIN 2 0.0001
787 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
788 RENAL DISORDER 6 0.0001
789 DELUSION 2 0.0001
790 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
791 NERVOUS SYSTEM DISORDER 4 0.0001
792 CYANOSIS 2 0.0001
793 DISEASE PROGRESSION 15 0.0001
794 DISORIENTATION 5 0.0001
795 DISEASE RECURRENCE 6 0.0001
796 COMA 6 0.0001
797 PRODUCT PRESCRIBING ERROR 3 0.0001
798 NECK PAIN 7 0.0001
799 PRURITUS 48 0.0001
800 BLOOD PRESSURE INCREASED 19 0.0001
801 LOCALISED INFECTION 3 0.0001
802 LIVER INJURY 3 0.0001
803 EYE IRRITATION 7 0.0001
804 AGEUSIA 3 0.0001
805 SYNCOPE 12 0.0001
806 ROAD TRAFFIC ACCIDENT 5 0.0001
807 HOT FLUSH 9 0.0001
808 PAIN IN EXTREMITY 35 0.0001
809 FLUID RETENTION 6 0.0001
810 COUGH 33 0.0001
811 MYALGIA 20 0.0001
812 SWELLING 11 0.0001
813 CIRCULATORY COLLAPSE 2 0.0001
814 HOSPITALISATION 18 0.0001
815 PERIPHERAL SWELLING 18 0.0001
816 DYSPNOEA 66 0.0001
817 HYPERHIDROSIS 15 0.0001
818 UNRESPONSIVE TO STIMULI 3 0.0001
819 MUSCULOSKELETAL DISCOMFORT 2 0.0001
820 NEUROTOXICITY 2 0.0001
821 NASOPHARYNGITIS 21 0.0001
822 HEART RATE DECREASED 4 0.0001
823 SLEEP DISORDER 8 0.0001
824 BRADYCARDIA 6 0.0001
825 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
826 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
827 EAR INFECTION 3 0.0001
828 FATIGUE 87 0.0001
829 CEREBRAL HAEMORRHAGE 4 0.0001
830 MOBILITY DECREASED 8 0.0001
831 MYELOSUPPRESSION 4 0.0001
832 GASTROENTERITIS VIRAL 2 0.0001
833 UNDERDOSE 8 0.0001
834 MUSCLE SPASMS 20 0.0001
835 AGRANULOCYTOSIS 2 0.0001
836 SWELLING FACE 7 0.0001
837 CHEST DISCOMFORT 11 0.0001
838 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
839 MIDDLE INSOMNIA 2 0.0001
840 ALOPECIA 21 0.0001
841 ILLNESS 11 0.0001
842 EYE PAIN 6 0.0001
843 BLOOD SODIUM DECREASED 2 0.0001
844 BLOOD PRESSURE DECREASED 7 0.0001
845 HAEMORRHAGE 11 0.0001
846 MUSCULOSKELETAL DISORDER 2 0.0001
847 RED BLOOD CELL COUNT DECREASED 3 0.0001
848 VISUAL IMPAIRMENT 13 0.0001
849 MIGRAINE 10 0.0001
850 BALANCE DISORDER 9 0.0001
851 CONTUSION 10 0.0001
852 GLAUCOMA 2 0.0001
853 ERUCTATION 2 0.0001
854 LIVER FUNCTION TEST ABNORMAL 3 0.0001
855 DYSTONIA 2 0.0001
856 NEEDLE ISSUE 3 0.0001
857 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
858 HYPERSENSITIVITY 19 0.0001
859 SURGERY 6 0.0001
860 MEMORY IMPAIRMENT 14 0.0001
861 LABORATORY TEST ABNORMAL 3 0.0001
862 INSOMNIA 27 0.0001
863 GASTROINTESTINAL DISORDER 9 0.0001
864 FULL BLOOD COUNT DECREASED 2 0.0001
865 CORONARY ARTERY DISEASE 3 0.0001
866 DRY MOUTH 8 0.0001
867 DYSKINESIA 4 0.0001
868 PRODUCT PREPARATION ERROR 2 0.0001
869 CARDIAC ARREST 8 0.0001
870 CARDIAC DISORDER 9 0.0001
871 CARDIO-RESPIRATORY ARREST 4 0.0001
872 DRUG-INDUCED LIVER INJURY 3 0.0001
873 PARAESTHESIA 15 0.0001
874 WITHDRAWAL SYNDROME 4 0.0001
875 HYPOTHYROIDISM 3 0.0001
876 DRUG INTOLERANCE 9 0.0001
877 HYPOACUSIS 4 0.0001
878 POOR QUALITY SLEEP 2 0.0001
879 HALLUCINATION 7 0.0001
880 DEPRESSION 21 0.0001
881 ABDOMINAL PAIN UPPER 19 0.0001
882 DEVICE LEAKAGE 4 0.0001
883 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
884 HEART RATE INCREASED 9 0.0001
885 EXPIRED PRODUCT ADMINISTERED 3 0.0001
886 LIP SWELLING 3 0.0001
887 PANCREATITIS ACUTE 2 0.0001
888 ASTHMA 10 0.0001
889 PRODUCT AVAILABILITY ISSUE 2 0.0001
890 FEELING ABNORMAL 21 0.0001
891 CONVULSION 5 0.0001
892 MUSCLE TWITCHING 2 0.0001
893 NEOPLASM PROGRESSION 3 0.0001
894 ARRHYTHMIA 4 0.0001
895 TREMOR 14 0.0001
896 THERAPY INTERRUPTED 6 0.0001
897 PRODUCTIVE COUGH 4 0.0001
898 URTICARIA 14 0.0001
899 BLOOD GLUCOSE DECREASED 4 0.0001
900 DIABETIC KETOACIDOSIS 2 0.0001
901 DRUG EFFECT INCOMPLETE 3 0.0001
902 THERAPEUTIC RESPONSE DECREASED 5 0.0001
903 DIZZINESS 41 0.0001
904 DRUG INTERACTION 13 0.0001
905 AGITATION 6 0.0001
906 DYSGEUSIA 6 0.0001
907 LEUKOPENIA 4 0.0001
908 ACNE 6 0.0001
909 GASTRIC CANCER 2 0.0001
910 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
911 APPLICATION SITE ERYTHEMA 2 0.0001
912 DERMATITIS ATOPIC 4 0.0001
913 DRY SKIN 10 0.0001
914 MYOCARDIAL INFARCTION 13 0.0001
915 JAUNDICE 2 0.0001
916 BLOOD GLUCOSE INCREASED 14 0.0001
917 DISTURBANCE IN ATTENTION 4 0.0001
918 RASH PRURITIC 4 0.0001
919 ANXIETY 21 0.0001
920 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
921 VISION BLURRED 10 0.0001
922 TREATMENT FAILURE 6 0.0001
923 ANAPHYLACTIC REACTION 4 0.0001
924 RHABDOMYOLYSIS 3 0.0001
925 DEVICE DISLOCATION 3 0.0001
926 MENTAL DISORDER 3 0.0001
927 DYSPHONIA 4 0.0001
928 NASAL CONGESTION 4 0.0001
929 CATARACT 4 0.0001
930 THROAT IRRITATION 3 0.0001
931 IRRITABILITY 4 0.0001
932 PREMATURE BABY 2 0.0001
933 LACRIMATION INCREASED 2 0.0001
934 EMOTIONAL DISTRESS 8 0.0001
935 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
936 VERTIGO 4 0.0001
937 SKIN DISCOLOURATION 3 0.0001
938 DRUG ADMINISTRATION ERROR 2 0.0001
939 LIMB DISCOMFORT 2 0.0001
940 COGNITIVE DISORDER 3 0.0001
941 OCULAR HYPERAEMIA 3 0.0001
942 NEUROPATHY PERIPHERAL 6 0.0001
943 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
944 GAIT INABILITY 2 0.0001
945 EYE PRURITUS 2 0.0001
946 TOXICITY TO VARIOUS AGENTS 10 0.0001
947 GASTRIC DISORDER 2 0.0001
948 INJECTION SITE REACTION 4 0.0001
949 WEIGHT INCREASED 13 0.0001
950 NIGHTMARE 2 0.0001
951 DEVICE USE ERROR 2 0.0001
952 NERVOUSNESS 3 0.0001
953 DEATH 49 0.0001
954 SKIN BURNING SENSATION 4 0.0001
955 RHEUMATOID ARTHRITIS 6 0.0001
956 PLASMA CELL MYELOMA 2 0.0001
957 PALPITATIONS 6 0.0001
958 ABNORMAL BEHAVIOUR 2 0.0001
959 THROMBOSIS 4 0.0000
960 JOINT SWELLING 6 0.0000
961 BLINDNESS 2 0.0000
962 EXPOSURE DURING PREGNANCY 3 0.0000
963 HYPOAESTHESIA 7 0.0000
964 INJECTION SITE PAIN 14 0.0000
965 DRUG WITHDRAWAL SYNDROME 4 0.0000
966 DEVICE MALFUNCTION 3 0.0000
967 INJURY 3 0.0000
968 COLORECTAL CANCER 2 0.0000
969 MULTIPLE SCLEROSIS 2 0.0000
970 CEREBROVASCULAR ACCIDENT 7 0.0000
971 AGGRESSION 2 0.0000
972 UNEVALUABLE EVENT 3 0.0000
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
974 PANCREATITIS 2 0.0000
975 DEPRESSED MOOD 2 0.0000
976 INCORRECT DOSE ADMINISTERED 8 0.0000
977 PRODUCT SUBSTITUTION ISSUE 2 0.0000
978 DEVICE ISSUE 3 0.0000
979 ADVERSE EVENT 3 0.0000
980 AMNESIA 2 0.0000
981 PRODUCT DOSE OMISSION 2 0.0000
982 PRODUCT QUALITY ISSUE 4 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
984 INJECTION SITE SWELLING 2 0.0000
985 INJECTION SITE BRUISING 2 0.0000
986 PROSTATE CANCER 2 0.0000
987 INFLUENZA LIKE ILLNESS 2 0.0000
988 DRUG DOSE OMISSION 4 0.0000
989 PRODUCT STORAGE ERROR 2 0.0000
990 ADVERSE DRUG REACTION 2 0.0000
991 BREAST CANCER 2 0.0000
992 NO ADVERSE EVENT 3 0.0000
993 INJECTION SITE ERYTHEMA 2 0.0000